These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6510485)
1. Effect of two cyclophosphamide derivatives on hemopoietic progenitor cells and pluripotential stem cells. Porcellini A; Manna A; Talevi N; Sparaventi G; Marchetti-Rossi MT; Baronciani D; De Biagi M Exp Hematol; 1984 Dec; 12(11):863-6. PubMed ID: 6510485 [TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro effects of cyclophosphamide derivatives on murine bone marrow-derived stromal and hemopoietic progenitor cell classes. de Jong JP; Nikkels PG; Brockbank KG; Ploemacher RE; Voerman JS Cancer Res; 1985 Sep; 45(9):4001-5. PubMed ID: 3896474 [TBL] [Abstract][Full Text] [Related]
3. [A simple method for detecting immature precursors after in vitro bone marrow treatment with ASTA-Z 7654]. Lamana M; Fernández-Rañada JM Sangre (Barc); 1991 Dec; 36(6):501-3. PubMed ID: 1812583 [TBL] [Abstract][Full Text] [Related]
4. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide. Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568 [TBL] [Abstract][Full Text] [Related]
5. Late effects of chemotherapy on hematopoietic progenitor cells. Fried W; Adler S Exp Hematol; 1985; 13 Suppl 16():49-56. PubMed ID: 3886419 [TBL] [Abstract][Full Text] [Related]
6. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation. Lopez M; Mary JY; Sainteny F Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567 [TBL] [Abstract][Full Text] [Related]
7. Use of long-term human marrow cultures to demonstrate progenitor cell precursors in marrow treated with 4-hydroperoxycyclophosphamide. Winton EF; Colenda KW Exp Hematol; 1987 Jul; 15(6):710-4. PubMed ID: 3595769 [TBL] [Abstract][Full Text] [Related]
8. [The effect of cyclophosphamide on the erythropoietic stem cell compartment]. Milenković P Bilt Hematol Transfuz; 1980; 8(1):91-7. PubMed ID: 7337685 [TBL] [Abstract][Full Text] [Related]
9. Preferential differentiation of murine CFU-S toward granulopoiesis and megakaryocytopoiesis after in vitro incubation of bone marrow with ASTA-Z 7557. Sainteny F; Lopez M; Mary JY; Frindel E Exp Hematol; 1987 Jul; 15(6):631-5. PubMed ID: 3297759 [TBL] [Abstract][Full Text] [Related]
10. Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamide. Rowley SD; Colvin OM; Stuart RK Exp Hematol; 1985 May; 13(4):295-8. PubMed ID: 3987832 [TBL] [Abstract][Full Text] [Related]
11. Effect of the aldehyde dehydrogenase inhibitor, cyanamide, on the ex vivo sensitivity of murine multipotent and committed hematopoietic progenitor cells to mafosfamide (ASTA Z 7557). Kohn FR; Landkamer GJ; Sladek NE Immunopharmacol Immunotoxicol; 1987; 9(2-3):163-76. PubMed ID: 3437102 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow. De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785 [TBL] [Abstract][Full Text] [Related]
13. Effects of daunorubicin and doxorubicin, free and associated with DNA, on hemopoietic stem cells. Huybrechts M; Symann M; Trouet A Cancer Res; 1979 Sep; 39(9):3738-43. PubMed ID: 476697 [TBL] [Abstract][Full Text] [Related]
14. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients. Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069 [TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors. Wu DD; Nayar R; Keating A Exp Hematol; 1994 Jun; 22(6):495-500. PubMed ID: 7514543 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of amifostine (Ethyol) on normal hematopoietic stem cells versus human leukemic cells during ex vivo purging in autologous bone marrow transplants. Douay L; Hu C; Giarratana MC; Gorin NC Semin Oncol; 1994 Oct; 21(5 Suppl 11):16-20. PubMed ID: 7973773 [TBL] [Abstract][Full Text] [Related]
17. [Experimental bases of the in vitro treatment of leukemic bone marrow by a derivative of cyclophosphamide: ASTA Z 7557]. Douay L; Gorin NC; Mary JY; Duhamel G C R Acad Sci III; 1985; 301(6):303-8. PubMed ID: 3928107 [TBL] [Abstract][Full Text] [Related]
18. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice. Drize N; Chertkov J; Samoilina N; Zander A Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232 [TBL] [Abstract][Full Text] [Related]
19. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal. van Os R; Robinson S; Sheridan T; Mauch PM Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384 [TBL] [Abstract][Full Text] [Related]
20. In vitro chemosensitivity of leukemic progenitor cells (AML-CFU) to a combination of mafosfamide lysine (ASTA-Z 7654) and etoposide (VP16-213). Deconinck E; Tamayo E; Hervé P Bone Marrow Transplant; 1990 Jan; 5(1):13-8. PubMed ID: 2297586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]